xuffy26

PROTOCOL FOR
CALL OUTS
This work is the personal, unpublished, confidential, and
proprietary property of SYNLAB Nigeria, and may not be
disclosed, used, reproduced, distributed, recreated, modified,
displayed, or performed, in whole or in part, without the express
written consent of the QA Department of SYNLAB Nigeria.
All personnel concerned with this document must sign the
document to indicate that he/she is familiar with its contents.
Doc no: 066 – Protocols for Call Outs – Rev 1

xuffy26

Conflict of Interest Policy
Date: 01-04-2024
Chat360 Services Limited
Prepared By Karthik R – Head - HR Operations
Recommended By
Prashanth Utreja – Chief People Officer
Shelvin Mathews – Chief Risk Officer
Vikas Arora – Chief Compliance Officer
Approved By RMC
Approved Date 13-Mar-2024

xuffy26

https://www.durexindia.com/#MainContent
https://www.durexindia.com/
https://www.durexindia.com/collections/invisible-003
https://www.durexindia.com/collections/extra-time-ultra-thin
https://www.durexindia.com/collections/close-fit-invisible
https://www.durexindia.com/collections/extra-time
https://www.durexindia.com/collections/real-feel
https://www.durexindia.com/collections/mutual-base-products
https://www.durexindia.com/collections/durex-intense
https://www.durexindia.com/collections/invisible

xuffy26

Summary Tab
Project Trojan Project Design Criteria (PDC) - claims approval
Project NameTrojan - Ashwagandha 300mg and Shilajit 150mg Capsules
Project Number31964
Developed Under Accreditation Standard?NA
Target Launch DateQ3 2024
Lead Country & Key Roll-Out CountriesIndia
R&D LeadShilpy Arora
Project ChampionArth Dodeja
Formulation code(s)3308306